- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05418075
Evaluation of the Effectiveness of Add-on Hometreatment to Family Based Therapy in Adolescent Anorexia Nervosa. (HTED)
June 10, 2022 updated by: Psychiatric University Hospital, Zurich
Evaluation of the Effectiveness of Add-on Hometreatment to Family Based Therapy in Adolescent Anorexia Nervosa. A Randomised Controlled Clinical Trial
The project serves to evaluate a new treatment method with outreach services as a supplement to family-based therapy in the treatment of children and adolescents with eating disorders.
The project is intended to help identify different family structures and which families will benefit most from the new outreach service of home-based treatment.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zürich, Switzerland, 8032
- Recruiting
- Psychiatrische Universitätsklilnik Zürich
-
Contact:
- Nicole Flütsch, M.Sc.
- Phone Number: +41 0434992626
- Email: nicole.fluetsch@uzh.ch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 20 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Children and adolescents aged 12 -20 years.
- Successful registrations in the special consultation for eating disorders at the Clinic for Child and Adolescent Psychiatry and Psychotherapy (KJPP) of the Psychiatric University Hospital (PUK) Zurich.
- Diagnosis of anorexia nervosa or atypical anorexia nervosa (ICD-10 F50.00/ F50.01/ F50.1)
- Existing informed consent of patients* (14 years and older) and parents or legal guardians (12-14 years).
- IQ over 75
- Resident in the canton of Zurich
- Good knowledge of German
Exclusion Criteria:
- No written consent
- Children under 12 years
- Other forms of eating disorders apart from anorexia nervosa or atypical anorexia nervosa.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Home Treatment as add on to Familiy-based Treatment
|
If the families agree to participate in the study, they are randomly assigned to a treatment group.
In each of the three groups, they are treated with FBT in a weekly session.
In the two comparison groups, Hometreatment or MBSR are offered in addition to FBT, with two consultations per week in each case.
|
|
Active Comparator: Familiy-based Treatment
|
If the families agree to participate in the study, they are randomly assigned to a treatment group.
In each of the three groups, they are treated with FBT in a weekly session.
In the two comparison groups, Hometreatment or MBSR are offered in addition to FBT, with two consultations per week in each case.
|
|
Active Comparator: Mindfulness based stress reduction training
|
If the families agree to participate in the study, they are randomly assigned to a treatment group.
In each of the three groups, they are treated with FBT in a weekly session.
In the two comparison groups, Hometreatment or MBSR are offered in addition to FBT, with two consultations per week in each case.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Symptomatic improvement
Time Frame: 3 months
|
Change of the reported BMI; Weight in Kg and Height in cm will be combined to report BMI in kg/m^2
|
3 months
|
|
Symptomatic improvement
Time Frame: 3 months
|
Change of the Eating Disorder Examination Interview (EDE) total score analyze using a linear random coefficient regressions model
|
3 months
|
|
Symptomatic improvement
Time Frame: 3 months
|
Change of the Eating Disorder Inventory (EDI) total score analyze using a linear random coefficient regressions model
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
State of health improvement
Time Frame: 3 months
|
Change of the Perceived stress scale (PSS) total score measering level of perceived stress and change of the total score in Brief dyadic scale of expressed emotion (BDSEE) measering level of expressed emotion.
|
3 months
|
|
Remission rate
Time Frame: 12 months
|
Remission is definde as a Body weight within 15% deviation of the normal weight and clinically unremarkable values in the EDE and EDI
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2022
Primary Completion (Anticipated)
December 31, 2023
Study Completion (Anticipated)
December 31, 2024
Study Registration Dates
First Submitted
January 5, 2022
First Submitted That Met QC Criteria
June 10, 2022
First Posted (Actual)
June 14, 2022
Study Record Updates
Last Update Posted (Actual)
June 14, 2022
Last Update Submitted That Met QC Criteria
June 10, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HTED 2021-01706
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.